You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.
PHOENIX Wound Matrix is featured as an Innovative Technology in the July Issue of Wound Management and Prevention. | RenovoDerm partners with SDVOSB RegeniSource to offer ANTHEM Wound Matrix Fenestrated for our Veterans and Military - May 2021 | Dr. Mark Melin speaks about pH and the value of PHOENIX Wound Matrix on the Frank & Lizzie Show - June 2021 | RenovoDerm educated Podiatry Residents on pH and Changing the Dynamics of Wound Healing at the Combined Residency Summit Meeting - July 2021 | PHOENIX Wound Matrix will showcase its technology at SAWC Fall 2021 in Las Vegas.


NEW HCPCS code C1849 – Skin substitute, synthetic, resorbable per square centimeter

Effective July 1, 2020 the CMS HCPCS Workgroup created a new HCPCS code, C1849 for “Skin substitute, synthetic, resorbable, per square centimeter”. CMS has designated C1849 as a high-cost skin substitute under the Medicare Outpatient Prospective Payment System.

Please download our reimbursement overview and guide for Hospital Outpatient Clinics(HOPC) and Ambulatory Surgery Center(ASC) information.

Download Overview

For General Inquiries, Product Information, Reimbursement & Billing Questions: Please submit your request with the below form or call (614) 602-1852 for more information.


Information on reimbursement in the United States is provided as a courtesy. Due to the rapidly changing nature of the law and Medicare payment policy, and our reliance on information provided by outside sources, the information provided herein does not constitute a guarantee or warranty by RenovoDerm, Inc. that reimbursement will be received. This information is provided "AS IS" and without any other warranty or guarantee, expressed or implied, as to completeness or accuracy or otherwise. This information has been compiled based on data gathered from many primary and secondary sources, including the American Medical Association and certain Medicare contractors.